First human tests begin for new depression pill
NCT ID NCT07324408
Summary
This is a very early study to check the safety of a new drug called NH102, which is being developed to treat depression. It tested multiple dose levels in 40 healthy volunteers to see how their bodies reacted to and processed the drug. The main goal was to find out what side effects might occur and how the drug moves through the body, not to treat depression in this study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 201108, China
Conditions
Explore the condition pages connected to this study.